Infratil - Coming up for Air — Down to NEUTRAL
Investors in Infratil (IFT) have been richly rewarded over the last three decades, with total returns of almost +20% annually, or ~270x your money.
344 Views
Infratil - De-Risking CDC's Breakneck Growth
CDC now makes up nearly half of IFT's total asset value. We reiterate our OUTPERFORM rating with an increased target price of NZ$13.00.
160 Views
Infratil - FY24 Result — A Few Things to Unpick
Over the next three years CDC could triple in capacity, with EBITDA following close behind. CDC has tripled in capacity twice already. But scale...
253 Views
Infratil - FY24 Preview — One NZ Cash & CDC Growth
Infratil (IFT) will report its FY24 result on Tuesday, 21 May. With the reiteration of its guidance in March, we see little room for major...
204 Views
Infratil - Reinvestment Opportunities a Plenty
Infratil (IFT) and its portfolio companies delivered a confident message at its Investor Day, focused on the various long-term internal...
304 Views